Eric W. Van Den Neste

Brussels, BRU 1000, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications

Incidental Detection of Diffuse Large B-cell Lymphoma by Non-invasive Prenatal Testing: A Case Report.

Incidental Detection of Diffuse Large B-cell Lymphoma by Non-invasive Prenatal Testing: A Case Report.

Journal: Cureus
Published: May 17, 2026

Prognostic value of a simple distance index derived from PET maximum intensity projection.

Prognostic value of a simple distance index derived from PET maximum intensity projection.

Journal: Frontiers in medicine
Published: January 23, 2025

Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.

Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.

Journal: Cancers
Published: April 15, 2024

Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study).

Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study).

Journal: British journal of haematology
Published: February 11, 2024

The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study.

The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study.

Journal: HemaSphere
Published: February 06, 2024

Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.

Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 18, 2023

Intravascular large cell B lymphoma presenting as central nervous system pseudo-vasculitis: A rare diagnostic challenge.

Intravascular large cell B lymphoma presenting as central nervous system pseudo-vasculitis: A rare diagnostic challenge.

Journal: The neuroradiology journal
Published: November 07, 2023

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.

Journal: The Lancet. Haematology
Published: August 02, 2023

Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper.

Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper.

Journal: Hematological oncology
Published: March 03, 2022

Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group.

Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group.

Journal: Cancers
Published: February 13, 2022

Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?

Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?

Journal: Leukemia & lymphoma
Published: October 28, 2021

Richter transformation heralded by EBV reactivation during ibrutinib therapy for chronic lymphocytic leukemia.

Richter transformation heralded by EBV reactivation during ibrutinib therapy for chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma
Published: August 25, 2021
Showing 1-12 of 78

Last Updated: 09/26/2026